POST-TRANSLATIONAL MODIFICATIONS OF PROTEIN PHOSPHATASE 2A (PP2A) IN MIXED LINEAGE LEUKEMIA (MLL)

EHA Library, Yoana ARROYO, 266617

HACE1, A NOVEL TUMOR SUPPRESSOR GENE WHICH REGULATE THE RESPONSE OF VENETOCLAX, GANT61 AND NECROPTOSIS ACTIVATORS BY CONTROLLING C-FLIP, GLI2 AND BCL2 GENES IN ACUTE MYELOID LEUKEMIA

EHA Library, Andoni Garitano, 266618

RHOE, CXCL12 AND CXCR3 MAY IDENTIFY COMPLETE RESPONSES IN ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH TIPIFARNIB

EHA Library, Antonio Gualberto, 266619

HARMONY ALLIANCE: EUROPEAN PUBLIC-PRIVATE DATA COLLECTION LEADS THE WAY - FIRST RESULTS OF THE “PROOF-OF-PRINCIPLE” STUDY IN ACUTE MYELOID LEUKEMIA

EHA Library, Lars Bullinger, 266620

PTC299 IS A NOVEL DHODH INHIBITOR FOR USE IN TREATMENT OF AML

EHA Library, Marla Weetall, 266621

WHOLE-TRANSCRIPTOME SEQUENCING OF CYTOGENETICALLY NORMAL PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Lilit Ghukasyan, 266622

INHIBITORS OF HOXA9 LEUKEMOGENIC TRANSCRIPTION FACTOR ARE EFFICIENT ON HUMAN AML CELL MODELS BUT NOT ON NORMAL HUMAN BONE MARROW CD34+ HEMATOPOIETIC CELLS

EHA Library, Marie-Helene David, 266623

NORMAL AND LEUKEMIC BONE MARROW STROMAL CELLS HAVE DIFFERENT CAPACITIES FOR MITOCHONDRIA TRANSFER TO ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Mariane Cristina Do Nascimento, 266624

A NEW NEXT-GENERATION SEQUENCING STRATEGY FOR THE SIMULTANEOUS DETECTION OF GENE MUTATIONS AND COPY NUMBER VARIATIONS IN MYELOID MALIGNANCIES

EHA Library, Ramon Garcia-Sanz, 266625

INDIVIDUALIZED FOLLOW-UP IN ADULT ACUTE MYELOID LEUKEMIA USING NGS

EHA Library, Zuriñe Blasco Iturri, 266626

IDH2 GENE MUTATIONS DETECTION IN ACUTE MYELOID LEUKEMIA: SCREENING AND MRD MONITORING BY “DROP-OFF” DDPCR.

EHA Library, Susanna Grassi, 266627

MEASURABLE RESIDUAL DISEASE BY MULTIPARAMETRIC FLOW-CYTOMETRY IS A RELIABLE TOOL FOR RISK-STRATIFICATION OF FLT3-MUTATED AML PATIENTS.

EHA Library, Raffaele Palmieri, 266628

PREDICTING A PML-RARA FUSION GENE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA BY CONVOLUTIONAL NEURAL NETWORKS

EHA Library, Chia-Jen Liu, 266629

IS QUERCETIN ABLE TO REVERT THE APOPTOTIC RESISTANCE TRIGGERED BY THE SHORT ISOFORM OF GATA-1 IN MYELOID LEUKEMIA CELLS?

EHA Library, Silvia trombetti, 266630

GLYCOLYSIS VERSUS OXIDATIVE PHOSPHORYLATION - POTENTIAL THERAPEUTIC TARGETS IN AML

EHA Library, Ana Bela Sarmento-Ribeiro, 266631

SINGLE-CELL RNA-SEQUENCING & GENOTYPING OF PATIENTS WITH WT1-SUBCLONAL AML TO ELUCIDATE CLONAL HETEROGENEITY

EHA Library, Julia Niggemeyer, 266632

COMPARATIVE ANALYSES OF LEUKEMIC BLAST PHENOTYPE AND MUTANT/WT EXPRESSION RATIO IN FLT3-ITD ACUTE MYELOID LEUKEMIAS

EHA Library, Dan Soare, 266633

MICRO RNA SIGNATURE OF ONCOGENIC MUSASHI RNA BINDING PROTEINS MSI1 AND MSI2

EHA Library, Sujitha Duggimpudi, 266634

TUMOR IMMUNE ESCAPE MEDIATED BY TH17CCR4-CCR6+ CELLS AND IL-6/IL-10/IL-17A IN ACUTE MYELOID LEUKEMIA

EHA Library, Amaya Zabalza, 266635

HIGH CYTOMEGALOVIRUS VIRUS LOAD INDUCES A POTENT TUMOR-SPECIFIC CD8+ T CELL RESPONSE AND PROTECTS PATIENT IN ACUTE MYELOID LEUKEMIA FROM RELAPSE AFTER SINGLE CORD BLOOD TRANSPLANTATION

EHA Library, Zimin Sun, 266636

SNP ARRAY REVEALS A NEW DELETION OF JAK2 IN AML PATIENTS

EHA Library, Claudio Cerchione, 266637

GOOD SENSITIVITY OF ACUTE MYELOID LEUKEMIAS INVOLVING ONLY GRANULOCYTE-MONOCYTE LINE (GM-AML) TO STANDARD-DOSE INDUCTION THERAPY (SICT) IS NOT INFLUENCED BY AGE

EHA Library, Petr Lemez, 266638

PREFERENTIAL TRANSCRIPTION OF THE MUTATED ALLELE IN NPM1 MUTATED ACUTE MYELOID LEUKAEMIA

EHA Library, Graham Bailey, 266639

MUTANT IDH1 INHIBITOR IVOSIDENIB (AG-120) IN COMBINATION WITH AZACITIDINE FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Courtney D. DiNardo, 266640

IMPACT OF MINIMAL RESIDUAL DISEASE AND COMPLETE REMISSION (CR)/CR WITH PARTIAL HEMATOLOGIC RECOVERY ON SURVIVAL AFTER GILTERITINIB THERAPY IN PATIENTS WITH FLT3-MUTATED RELAPSED/REFRACTORY AML

EHA Library, Mark Levis, 266641

IVOSIDENIB (AG-120) INDUCES DURABLE REMISSIONS AND TRANSFUSION INDEPENDENCE IN PATIENTS WITH IDH1-MUTANT NEWLY-DIAGNOSED AML: UPDATED RESULTS FROM A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY

EHA Library, Gail J. Roboz, 266642

ENASIDENIB ASSOCIATED WITH IMPROVED SURVIVAL COMPARED WITH STANDARD OF CARE FOR R/R AML PATIENTS WITH AN IDH2 MUTATION BASED ON DATA FROM STUDY AG221-C-001 AND A REVIEW OF PATIENT CHARTS IN FRANCE

EHA Library, Stephane DE BOTTON, 266643

ASSESSMENT OF MOLECULAR MRD KINETICS BY ERROR-CORRECTED NEXT-GENERATION SEQUENCING PROVIDES INDEPENDENT PROGNOSTIC INFORMATION IN ADULT AML PATIENTS

EHA Library, Tracy Murphy, 266644

ALLG APML5: A COMPARATIVE BIOAVAILABILITY STUDY OF ENCAPSULATED ORAL ARSENIC TRIOXIDE AND INTRAVENOUS ARSENIC TRIOXIDE IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA UNDERGOING CONSOLIDATION THERAPY

EHA Library, Harry J Iland, 266645

CLINICAL BENEFIT OF GLASDEGIB PLUS LOW-DOSE CYTARABINE IN PATIENTS WITH DE NOVO AND SECONDARY ACUTE MYELOID LEUKEMIA: LONG-TERM ANALYSIS OF A PHASE 2 RANDOMIZED TRIAL

EHA Library, Walter Fiedler, 266646

COMPLETE REMISSION WITH INCOMPLETE BLOOD COUNT RECOVERY IS A STRONG PREDICTOR OF NON-RELAPSE MORTALITY IN ACUTE MYELOID LEUKEMIA PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Ivetta Danylesko, 266647

DECITABINE VERSUS INTENSIVE CHEMOTHERAPY IN ELDERLY UNTREATED ACUTE MYELOID LEUKEMIA

EHA Library, Adolfo De La Fuente, 266648

SURVIVAL FROM ACUTE MYELOID LEUKEMIA HAS SINCE 1997 IMPROVED ONLY IN MALES AGED 50-75 YEARS - A SWEDISH POPULATION-BASED STUDY

EHA Library, Gunnar JULIUSSON, 266649

A PROOF OF CONCEPT OF LSD1-INHIBITON IN A PHASE I/II PILOT TRIAL OF TCP AND ATRA IN REFRACTORY / RELAPSED AML PATIENTS NOT ELIGIBLE FOR INTENSIVE THERAPY

EHA Library, Maxi Wass, 266650

PHASE I DOSE ESCALATION CLINICAL TRIAL OF H3B-8800, A SPLICING MODULATOR, IN PATIENTS WITH ADVANCED MYELOID MALIGNANCIES

EHA Library, David Steensma, 266651

GEMTUZUMAB OZOGAMICINE-BASED SALVAGE THERAPIES IN REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Sonia Jaramillo Segura, 266652

UPDATED RESULTS FROM A PHASE 1 STUDY OF GILTERITINIB IN COMBINATION WITH INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED AML

EHA Library, Alexander Perl, 266653

FINAL REPORT: CLINICAL STUDY OF ORAL ARSENIC TRIOXIDE CAPSULE FORMULATION, ORH-2014, DEMONSTRATING HIGH BIOAVAILABILITY, GOOD SAFETY AND TOLERABILITY IN PATIENTS WITH ADVANCED HEMATOLOGIC DISORDERS

EHA Library, Farhad Ravandi, 266654

FLT3 TESTING IN THE RYDAPT ERA

EHA Library, Stuart Scott, 266655

ROBUST IDENTIFICATION OF CLINICALLY RELEVANT MUTATIONS IN AML USING RNA-SEQ

EHA Library, Muxin Gu, 266656

DETECTION OF MRD MAY PREDICT THE OUTCOME OF PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH BIALLELIC CEBPA MUTATIONS

EHA Library, Jing Wang, 266657

TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH IDH2-MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA - A FRENCH MEDICAL CHART REVIEW ANALYSIS

EHA Library, Arnaud Pigneux, 266658

ISOCITRATE DEHYDROGENASE 1/2 MUTATIONS AND ASSOCIATIONS IN ACUTE MYELOID LEUKEMIA

EHA Library, Petra Kovy, 266659

OUTCOMES OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA: A POPULATION-BASED REAL-WORLD STUDY

EHA Library, Joseph M. Brandwein, 266660

THE PROGNOSTIC SIGNIFICANCE OF BCR-1 AND BCR-3 ISOFORM OF PML-RARA AND FLT3-ITD IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Mosaad El Gammal, 266661

INDIRECT NUMBER NEEDED TO TREAT: COMPARATIVE EFFECTIVENESS OF GLASDEGIB + LOW-DOSE CYTARABINE VS AZACITIDINE OR DECITABINE IN ACUTE MYELOID LEUKEMIA PATIENTS INELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Anna Forsythe, 266662

FLT3 LIGAND PLASMA LEVELS HAVE NO IMPACT ON OUTCOMES AFTER ALLOTRANSPLANT IN ACUTE LEUKEMIA.

EHA Library, Pierre Peterlin, 266663

EFFICACY AND SAFETY EVALUATION OF DIFFERENT DOSES OF ANTHRACYCLINES IN THE INDUCTION THERAPY FOR NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Xiaohui Hu, 266664

BASELINE SERUM LEVELS OF RECEPTORS FOR INTERLEUKIN-2 AND TUMOR NECROSIS FACTOR-Α PREDICT OVERALL SURVIVAL IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Tomas Kupsa, 266665

COMPARATIVE RANDOMIZED STUDY OF PROTOCOL HAM VERSUS PROTOCOL FLAG IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Alyaa elsergany, 266666

MARKER CHROMOSOME IS A STRONG POOR PROGNOSIS FACTOR AFTER ALLOGENEIC HSCT FOR AML PATIENTS

EHA Library, Kyok Fuse, 266667

FT-2102, AN IDH1M INHIBITOR, INDUCES MUTATION CLEARANCE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS) TREATED IN PHASE 1 DOSE ESCALATION AND EXPANSION STUDY

EHA Library, Stephane DE BOTTON, 266668

AGE >70 YEARS, HIGH-RISK CYTOGENETICS, SORROR COMORBIDITY SCORE >1 AND BLAST COUNT>40% IN BM ARE RISK FACTORS FOR INDUCTION FAILURE OF STANDARD CHEMOTHERAPY WITH ANTHRACYCLINE AND CYTARABINE IN AML

EHA Library, Ahmet ELMAAGACLI, 266669

IMPACT OF CYTOMEGALOVIRUS REACTIVATION ON RELAPSE RATE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA

EHA Library, Nour Ben Adejlil, 266670

INTENSIFIED CONDITIONING WITH FLUDARABINE/MELPHALAN PLUS TOTAL BODY IRRADIATION VERSUS FLUDARABINE/MELPHALAN ALONE FOR ACUTE MYELOID LEUKEMIA

EHA Library, Sarah Lindner, 266671

NEGATIVE MINIMAL RESIDUAL DISEASE STATUS BY MULTICOLOUR FLOW CYTOMETRY AFTER 1ST COURSE IS THE MOST PREDICTIVE FACTOR FOR AML PATIENTS

EHA Library, Tatiana Lobanova, 266672

ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME WITH CHROMOSOME 17 ABNORMALITIES AND LONG-TERM OUTCOMES WITH OR WITHOUT HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Ghulam Rehman Mohyuddin, 266673

INDUCTION WITH FLUGA SCHEME AND MAINTENANCE WITH DECITABINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA OF 65 YEARS AND OLDER

EHA Library, Sofia Belen COSTA, 266674

NOVEL CIRCULATING TUMOR DNA (CTDNA) BASED DDPCR DROP-OFF ASSAYS FOR IMPROVED DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA (AML) A “LIQUID BIOPSY” FOR A “LIQUID TUMOR”

EHA Library, Christian Rausch, 266675

DEFINING TRANSIENT ABNORMAL MYELOPOIESIS BY GATA1 MUTATION IN INFANTS WITH DOWN SYNDROME

EHA Library, Iman Ragab, 266676

CO-OCCURRENCE OF DNMT3A-R882, FLT3 AND NPM1 MUTATIONS IDENTIFIES A SUBSET OF AML PATIENTS WITH ADVERSE PROGNOSIS

EHA Library, Matheus F Bezerra, 266677

ELDERLY PATIENTS WITH DE NOVO OR SECONDARY AML HAVE COMPARABLE OUTCOMES AFTER INTENSIVE TREATMENTS INCLUDING HIGH DOSE (HD) CYTARABINE AND AUTOLOGOUS (AUTO) OR ALLOGENEIC (ALLO) TRANSPLANTATION (SCT)

EHA Library, massimo bernardi, 266678

PEDIATRIC ACUTE MYELOID LEUKEMIA (AML) IN DEVELOPING COUNTRIES, BARRIERS AGAINST BETTER OUTCOME 10 YEARS’ EXPERIENCE AMONG EGYPTIAN PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Youssef Madney, 266679

RESULTS OF PIVOTAL PHASE 2 CLINICAL TRIAL OF TAGRAXOFUSP (SL-401) IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)

EHA Library, Naveen Pemmaraju, 266680

EXPLORATORY ANALYSIS OF OUTCOMES WITH SEQUENTIAL FLT3-INHIBITOR (FLT3I) BASED THERAPIES IN RELAPSED FLT3-MUTATED AML PATIENTS (PTS)

EHA Library, Masnour Alfayez, 266681

OPEN-LABEL STUDY OF GILTERITINIB, GILTERITINIB PLUS AZACITIDINE, OR AZACITIDINE ALONE IN NEWLY DIAGNOSED FLT3-MUTATED AML PATIENTS INELIGIBLE FOR INTENSIVE CHEMOTHERAPY: RESULTS FROM THE SAFETY COHORT

EHA Library, Jordi Esteve, 266682

AXICABTAGENE CILOLEUCEL (AXI-CEL) IN REFRACTORY LARGE B CELL LYMPHOMA: OUTCOMES IN PATIENTS ≥ OR < 65 YEARS OF AGE IN THE PIVOTAL PHASE 1/2 ZUMA-1 STUDY

EHA Library, Sattva S. Neelapu, 266683

AXICABTAGENE CILOLEUCEL (AXI-CEL) IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA: PRELIMINARY RESULTS OF EARLIER STEROID USE

EHA Library, Max S. Topp, 266684

SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI-CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Emma Verner, 266685

THE ECHELON-2 TRIAL: RESULTS OF A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF BRENTUXIMAB VEDOTIN AND CHP (A+CHP) VERSUS CHOP IN FRONTLINE TREATMENT OF PATIENTS WITH CD30+ PERIPHERAL T-CELL LYMPHOMAS

EHA Library, Tim Illidge, 266687

SURVIVAL OF B-CELL LYMPHOMAS IN THE PRE- AND POST-RITUXIMAB ERAS: 30 YEARS REAL-WORLD DATA

EHA Library, Mohamed Gouda, 266689

PRELIMINARY RESULTS OF ASTX660, A NOVEL NON-PEPTIDOMIMETIC CIAP1/2 AND XIAP ANTAGONIST, IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA AND CUTANEOUS T CELL LYMPHOMA

EHA Library, Amitkumar Mehta, 266690

SANDOZ RITUXIMAB FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA: INTERIM SAFETY RESULTS OF THE PROSPECTIVE NON-INTERVENTIONAL, OBSERVATIONAL, MULTICENTER, OPEN-LABEL REFLECT STUDY

EHA Library, Manfred Welslau, 266691

ANTITUMOR ACTIVITY OF PEMBROLIZUMAB PLUS DINACICLIB IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA: THE PHASE 1B KEYNOTE-155 STUDY

EHA Library, Gareth Gregory, 266692

PROGNOSTIC IMPACT OF BCL2 AND MYC EXPRESSION AND TRANSLOCATION AMONG NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS TREATED WITH R-CHOP IN THE REAL WORLD

EHA Library, MK Downer, 266693

EVENT FREE SURVIVAL AT 12 MONTHS AND 24 MONTHS AS PREDICTORS FOR OUTCOME OF SYSTEMIC PERIPHERAL T CELL LYMPHOMA: ANALYSIS OF NATIONWIDE THAI LYMPHOMA STUDY GROUP

EHA Library, Kitsada Wudhikarn, 266694

A PHASE II STUDY OF FRACTIONATED CYCLOPHOSPHAMIDE, VINBLASTINE, ORAL ETOPOSIDE AND PREDNISOLONE IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME RELATED LYMPHOMAS

EHA Library, Hasmukh Jain, 266695

CLINICAL OUTCOME OF INTENSIFIED CHEMO-TARGETED THERAPY IN ACTIVATED B CELL NON HODGKIN LYMPHOMA

EHA Library, Ahmed Sohaib, 266696

LYMPHOMA ASSOCIATED HEMOPHAGOCYTIC SYNDROME: A SINGLE-CENTER EXPERIENCE.

EHA Library, Javier Alberto Rojas Martínez, 266697

PLATELET REACTIVITY AND RESPONSE TO ANTIPLATELET DRUGS IN THROMBOCYTOPENIA AND THROMBOCYTOSIS

EHA Library, Lidia USNARSKA-ZUBKIEWICZ, 267098

EFFECT OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RAS) ON ENDOTHELIAL CELLS AND NEUTROPHIL EXTRACELLULAR TRAP (NET) FORMATION IN IMMUNE THROMBOCYTOPENIA (ITP)

EHA Library, Lamya Garabet, 267099

IMPACT OF NEXT GENERATION SEQUENCING ON DIAGNOSIS OF INHERITED THROMBOCYTOPENIAS

EHA Library, Darya Fedorova, 267100

NOVEL ADAMTS13 MUTATIONS IN A PATIENT OF INHERITED THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Li Zhou, 267101

TRAMETINIB RESTORES IMMUNE TOLERANCE IN ITP PATIENTS BY MODULATING IRF4-MEDIATED TH1 AND TREG CELLS

EHA Library, Haoyi Wang, 267102

INTERLEUKIN-33 IN PEDIATRIC PATIENTS WITH IMMUNE THROMBOCYTOPENIA: RELATION TO PROGNOSIS AND TREATMENT OUTCOME

EHA Library, AZZA ABDELGAWAD TANTAWY ZAGHLOUL, 267103

EFFECT OF PLASMA EXCHANGE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF CAPLACIZUMAB

EHA Library, Rui Sousa, 267104

ATYPICAL HAEMOLYTIC URAEMIC SYNDROME IN THE ECULIZUMAB ERA: PRESENTATION, RESPONSE TO TREATMENT AND EVALUATION OF AN ECULIZUMAB WITHDRAWAL STRATEGY

EHA Library, Lucy Neave, 267105

TH1 CYTOKINE IFN-GAMMA+874T/A AND TNF-ALPHA-857C/T POLYMORPHISMS AFFECT THROMBOCYTOPENIA IN CHRONIC IMMUNE THROMBOCYTOPENIA (CITP)

EHA Library, Kana Souma, 267106

BERBERINE MAY CORRECT GUT MICROBIOTA-INDUCED CORTICOSTEROID RESISTANCE AND MESENCHYMAL STEM CELL DYSFUNCTION IN IMMUNE THROMBOCYTOPENIA BY REGULATING GUT MICROBIOTA STRUCTURE

EHA Library, Yanan Wang, 267107

PLATELET KINETICS IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA TREATED WITH THROMBOPOIETIN RECEPTOR AGONISTS

EHA Library, Zlatko Pravdic, 267108

ASSESSING TREATMENT RESPONSE IN CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA WITH AN INNOVATIVE SHEAR FLOW-BASED ASSAY

EHA Library, Chiara Vendramin, 267109

NEXT-GENERATION SEQUENCING REVEALS DISTINCT EXPANDED T-CELL RECEPTOR (TCR) Β-CHAIN CLONOTYPES IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)

EHA Library, Amna Malik, 267110

FUNCTIONAL ASSAYS USING WASHED PLATELETS FOR HEPARIN-INDUCED THROMBOCYTOPENIA DIAGNOSIS: A RETROSPECTIVE STUDY COMPARING HEPARIN- INDUCED PLATELET ACTIVATION TEST VERSUS 14C-SEROTONIN RELEASE ASSAY

EHA Library, Vasiliki Gkalea, 267112

ANKRD26-RELATED THROMBOCYTOPENIA: STUDY OF 3 FAMILIES

EHA Library, Daniela Pereira Coelho, 267113

NEUTROPHIL EXTRACELLULAR TRAPS (NETS), BLOOD CELL COUNTS AND THROMBOTIC RISK IN ITP PATIENTS

EHA Library, María Lozano, 267114

INCREASED RHOA ACTIVITY DUE TO A DISRUPTED FILAMIN A/ALPHAIIBΒETA3 INTERACTION INDUCES MACROTHROMBOCYTOPENIA

EHA Library, Alessandro Donada, 267115

THE EMOTIONAL IMPACT OF WATCH AND WAIT FOR CLL

EHA Library, Zack Pemberton-Whiteley, 267116

HEALTHCARE RESOURCE UTILIZATION (HCRU) IN PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) ACUTE MYELOID LEUKEMIA (AML) TREATED IN THE CONNECT® MDS/AML DISEASE REGISTRY

EHA Library, Sudipto Mukherjee, 267117

QUALITY OF LIFE IN PATIENTS UNDERGOING CHIMERIC ANTIGEN RECEPTOR (CAR) - T CELL THERAPY VS. AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANT FOR HEMATOLOGIC MALIGNANCIES

EHA Library, Surbhi Sidana, 267118

VALIDATION OF HAND GRIP STRENGTH AS A SCREENING TOOL FOR FRAILTY IN OLDER PATIENTS ON TREATMENT FOR HEMATOLOGIC MALIGNANCIES: THE FRAILTY TASK FORCE STUDY

EHA Library, Tommasina GUGLIELMELLI, 267119